Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KeraFactor is a biotechnology company specializing in hair and scalp health through the application of advanced growth factor and peptide science. The company's core technology is the KeraFactor Peptide Complex (KFP), a proprietary formulation of seven specific recombinant growth factors and proteins that are typically deficient in thinning hair. These proteins are encapsulated in nanoliposomes to ensure significantly higher absorption and delivery to the hair follicles compared to traditional topicals. KeraFactor's products are utilized both as standalone at-home treatments and in combination with clinical procedures, most notably the KeraLase treatment developed in partnership with Lutronic. This synergistic approach uses laser technology to create micro-channels in the scalp, facilitating deeper penetration of the KFP serum. The company aims to provide a non-hormonal, needle-free alternative for patients experiencing androgenetic alopecia and other forms of hair loss.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KeraFactor.